Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
CAS #: 89030-95-5 Testing & Quality Assurance Testing & Quality Assurance Trust starts with transparency
Always verify products through independent peptide testing laboratories and source from reputable suppliers with documented quality control processes
Interaction with other medications : Some medications like antihyperglycemic drugs (such as insulin and sulfonylureas), androgens, and beta blockers may lower glucose levels when used along with retatrutide
Also watch for reduced effectiveness at your usual dose, which may indicate potency loss
Activation of GLP-1R in these cells can be monitored by measuring luciferase activity
Other incretin projects : Lilly acquired Protomer Technologies in late 2024 specifically to get access to novel glucagon/GLP-1 peptides and oral incretins
